Ciprofloxacin Oral Tablets bulk supplier for pharma manufacturers

Ciprofloxacin Oral Tablets 250 mg, 500 mg, 750 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 250 mg, 500 mg, 750 mg

Reference Brands: Cipro(US & EU)

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication. This prevents bacterial growth and leads to cell death. It effectively treats urinary, respiratory, and gastrointestinal infections. Benefits include rapid, broad-spectrum activity, good tissue penetration, and convenient oral dosing for effective infection management.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ciprofloxacin Oral Tablets? List it or send an offer →

Product Description:

Ciprofloxacin tablets are approved in the EU and US for treating urinary, respiratory, skin, and gastrointestinal infections. In the EU, brands like Cipro are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generics are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and safety monitoring. We support seamless market access for ciprofloxacin, ensuring adherence to European and American standards for safe, effective antibiotic therapy in diverse infections.

Ciprofloxacin Oral Tablets — third party manufacturing & bulk supply

Ciprofloxacin Oral Tablets 250 mg, 500 mg, 750 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ciprofloxacin Oral Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ciprofloxacin Oral Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ciprofloxacin Oral Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ciprofloxacin tablets are used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections, and certain sexually transmitted infections. They help eliminate bacteria by stopping their growth and preventing the infection from spreading.

Ciprofloxacin tablets contain the active ingredient ciprofloxacin hydrochloride, which belongs to the fluoroquinolone class of antibiotics. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, which are essential for bacterial DNA replication and survival.

Ciprofloxacin tablets are marketed under trade names such as Cipro, Ciproxin, and Ciprobay.

Ciprofloxacin was originally developed by Bayer and marketed under the brand name Cipro. Today, ciprofloxacin tablets are manufactured by numerous pharmaceutical companies worldwide as both branded and generic products.

The generic name is ciprofloxacin hydrochloride.

Brand names include Cipro, Ciproxin, Ciprobay, Cifran, and other branded generic products.

Ciprofloxacin tablets are manufactured by multiple pharmaceutical companies in the United States, Europe, India, and other global pharmaceutical markets.